Genfit annual combined general meeting of june 17, 2025 — availability of preparatory documents

Lille (france); cambridge (massachusetts, united states); zurich (switzerland); may 7, 2025 - genfit (nasdaq and euronext: gnft), a biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today announced that it published in the may 7, 2025 french legal announcements bulletin n°55 (bulletin des annonces lÉgales obligatoires) its convening notice that the combined shareholders meeting will be held on june 17, 2025, at 10:00 am (cet), at the faculty of pharmaceutical sciences in lille, located at parc eurasantÉ, 3 rue du professeur laguesse, 59000 lille, france.
GM Ratings Summary
GM Quant Ranking